Auszug
Invasive Karzinome der Cervix uteri treten bei ca. 8/100.000 Frauen/Jahr (zervikale Präkanzerosen 100fach häufiger) auf. Das lebenslanges Risiko für Präkanzerosen beträgt ca. 1%.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bader A, Winter R, Haas J, Tamussino K (2007) Where to look for the sentinel lymph-node in cervical cancer. Am J Obstet Gynecol 197: 678.e1–678.e7
Benedet J, Anderson G (1996) Stage IA carcinoma of the cervix revisited. Obstet Gynecol 87: 1052–1059
Benedetti-Panici P, Greggi S, Colombo A et al. (2001) Neoadjuvant chemotherapy and radical surgery versus exclusive radio therapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 20: 179–188
Burghardt E (1984) Kolposkopie, spezielle Zervixpathologie. Thieme, Stuttgart New York
Burghardt E, Baltzer J, Tulusan H, Haas J (1992) Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 70: 648–655
Chou H, Chang T, Yen T et al. (2006) Low value of 18-F-fluoro-2-deoxy-D-glucose-positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol 24: 123–128
Eifel P, Winter K, Morris M et al. (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 22: 872–880
Friedberg V, Herzog R (1988) Die Therapie des Zervixkarzinoms. In: Friedberg V, Thomsen K (Hrsg) Gynäkologie und Geburtshilfe. Spezielle Gynäkologie 2. Thieme, Stuttgart New York, S 134–161
Future II study group (2007) Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomised clinical trials. Lancet 369: 1861–1868
Fyles AW, Milosevic M, Pintilie M et al. (2000) Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 57: 13–19
Girardi F, Pickel H, Winter R (1993) Pelvic and parametrial lymph nodes in the quality control of the surgical treatment of cervical cancer. Gynecol Oncol 50: 330–333
Hacker N, Wain G, Nicklin J (1995) Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 5: 250–256
Joura E, Leodolter S, Hernandez-Avila M et al. (2007) Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 369: 1693–1702
Kapp KS, Stuecklschweiger GF, Kapp DS et al. (1997) Carcinoma of the cervix; analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy Radiother Oncol 42: 143–153
Kapp KS, Poschauko J, Geyer E et al. (2002) Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 54: 58–66
Kaufmann M, Costa SD, Scharl A (Hrsg) (2003) Die Gynäkologie. Springer, Berlin Heidelberg New York
Landoni F, Maneo A, Colombo A et al. (1997) Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350: 535–540
Lee J, Lee K, Nam J et al. (2007) Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: Results of a multi-center retrospective Korean study. Ann Oncol 19: 321–326
Mayrand M, Duarte-Franco E, Rodrigues I et al. (2007) Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357: 1579–1588
Peters WA, Liu P, Barrett R et al. (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk earlystage cancer of the cervix. J Clin Oncol 18: 1606–1613
Petru E, Tamussino K, Lahousen M et al. (1989) Pelvic and para aortic lymphocysts after radical surgery because of cervical and ovarian cancer. Am J Obstet Gynecol 161: 937–941
Petru E, Pasterk C, Reich O et al. (2005) Small cell carcinoma of the uterus and vagina. Experience with ten patients. Arch Gynecol Obstet 271: 316–319
Podczaski E, Palombo C, Manetta A et al. (1989) Assessment of pretreatment laparotomy in patients with cervical carcinoma prior to radiotherapy. Gynecol Oncol 33: 71–75
Reich O, Lahousen M, Pickel H et al. (2002) Cervical intraepithelial neoplasia III: long-term follow-up after cold-knife coization with involved margins Obstet Gynecol 99: 193–196
Rose P, Bundy B, Watkins E et al. (1999) Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340: 1144–1153
Rotman M, Sedlis A, Piedmonte M et al. (2006) A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 65: 169–176
Sardi J, Sananes C, Giaroli A et al. (1993) Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix Gynecol Oncol 49: 156–165
Sawaya G, McConnell J, Kulasingam S et al. (2003) Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 349: 1501–1509
Shingleton H, Soong S, Gelder M et al. (1989) Clinical and histopathological factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 73: 1027–1034
Small W, Winter K, Levenback C et al. (2007) Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive paraaortic or high common iliac lymph nodes: Results of arm 1 of RTOG 0116. Int J Radiat Oncol Biol Phys 68: 1081–1087
Stehman FB, Bundy BN, DiSaia PJ et al. (1991) Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group Cancer 67: 2776–2785
Sutton G, Bundy B, Delgado G et al. (1992) Ovarian metastases in stage Ib carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol 166: 50–53
Vange V, Weverling G, Ketting B et al. (1995) The prognosis of cervical cancer associated with pregnancy: a matched chort study. Obstet Gynecol 85: 1022–1026
Webb M, Symmonds R (1980) Site of recurrence of cervical cancer after radical hysterectomy. Am J Obstet Gynecol 138: 813–817
Winter R, Petru E, Haas J (1988) Pelvic and para-aortic lymphadenectomy in cervical cancer. Baillieres Clin Obstet Gynaecol 2: 857–866
Winter R, Lahousen M, Haas J (1998) Long-term results in cervical cancer patients with positive paraaortic nodes. Gynecol Oncol 68: S107
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Petru, E., Kapp, K., Reich, O., Winter, R. (2009). Maligne Tumoren der Cervix uteri. In: Petru, E., Jonat, W., Fink, D., Köchli, O. (eds) Praxisbuch Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78327-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-540-78327-5_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78326-8
Online ISBN: 978-3-540-78327-5
eBook Packages: Medicine (German Language)